25-09-2012, 01:13 PM
DRUG MANUFACTURING AT REDDY’S LABS
DRUG MANUFACTURING.ppt (Size: 130.5 KB / Downloads: 39)
HISTORY
Established in 1984, Dr. Reddy's Laboratories Ltd.
(NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and News Chemical Entities.
PRODUCTS AND SERVICES OFFERED
Dr. Reddy's offers an unparalleled portfolio
to our customers comprising of innovators
and generic formulators worldwide.
With a strong product portfolio of products,
including niches like oncology and hormones,
and our “first in, last out” approach, it is little
wonder that we are today among the leading
generic API players globally.
Our goal is to enable
customers to be the first-to-launch a generic product as well as provide
value-added services that help them remain competitive and profitable
for the entire life cycle of the product. We have built the capabilities to
consistently deliver on this promise in scale and across the largest
product range.
A highly skilled global team focuses on timely delivery of products,
product development, technology leadership, cost competitiveness, the
highest levels of customer service, and full compliance with regulatory
and quality requirements.